RxDoctor Payments Data

Scott McGovern, MD

Orthopaedic Surgery of the Spine · Salisbury, MDNPI 1447236435

Payments from drug & device makers

What this record shows

This record is dominated by royalties or licence payments: $373,925 of the $430,625 with a category attached, or 86.8%. 17 manufacturers reported payments, led by Orthofix Medical, Inc. at 51.1% of the total.

$430,625in general payments, 2019–2025

Across 140 payments — averaging $3075.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Orthofix Medical, Inc.$220K
  • Seaspine Orthopedics Corporation$190K
  • Kuros Biosciences USA, Inc$9K
  • Stryker$7K
  • Globus Medical$1K
  • Abbott$1K
  • plus $3K from 11 others

What the payments were for

  • Royalty or licence$373,92587%
  • Consulting fees$33,5258%
  • Travel & lodging$19,9885%
  • Food & beverage$3,1871%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$430,625 in reported general payments places this provider in the 85th percentile of 49 orthopaedic surgery of the spine providers in Maryland.

See all orthopaedic surgery of the spine providers in Maryland

Medicare billing

Part B allowed, 2024
$408,118
Medicare patients
959
Services billed
2,435

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin170$1,196
Tizanidine Hcl36$198
Meloxicam33$155
Oxycodone Hcl15$127
Pregabalin11$87
Methylprednisolone14$64
Cyclobenzaprine Hcl14$58
Tramadol Hcl14$53

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery of the spine in Salisbury

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →